Related Experiment Video
Updated: Mar 17, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
Fast track program in liver resection: a PRISMA-compliant systematic review and meta-analysis
Emad Ali Ahmed1, Roberto Montalti, Daniele Nicolini
1Hepatobiliary and Abdominal Transplantation Surgery, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy Hepatobiliary and Pancreatic Surgery Unit, General Surgery Department, Sohag University, Sohag, Egypt.
The Enhanced Recovery After Surgery (ERAS) program significantly shortens hospital stays and speeds recovery for patients undergoing liver resection. This multimodal approach is safe and effective, with no increase in complications.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- The Enhanced Recovery After Surgery (ERAS) program, a multimodal approach, enhances postoperative rehabilitation and recovery.
- Initially developed for cardiac surgery, it has been adapted for colorectal and liver resections.
- Despite its acceptance, ERAS is not yet standard care in liver surgery.
Purpose of the Study:
- To systematically review and meta-analyze the impact of the ERAS program versus traditional care (TC) on clinical and surgical outcomes.
- To evaluate outcomes in patients undergoing elective liver resection.
Main Methods:
- A systematic search of PubMed/Medline, Scopus, and Cochran databases was conducted.
- Included studies compared ERAS with TC in elective liver resection.
- Subgroup analysis for laparoscopic and open approaches was performed; quality assessment and meta-analysis using Odds Ratios and Mean Differences were employed.
Main Results:
- The ERAS program significantly shortened length of hospital stay (LoS) in both open and laparoscopic liver resections.
- Accelerated functional recovery, decreased hospital costs, reduced operative time, and lower ICU admission rates were observed.
- No increase in readmission, morbidity, or mortality rates was found with the ERAS program.
Conclusions:
- The ERAS program is safe, feasible, and successfully applicable in liver resection.
- Further RCTs are recommended for issues like multimodal analgesia and adherence.
- Development of specific ERAS guidelines for liver resection is needed.
More Related Videos
11:03Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019